Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial
Registered in the Chinese Clinical Trial Register (ChiCTR2100042141).
Publications
View AllAffiliated Researchers
Institution Info
- Type
- healthcare
- Country
- CN
- Publications
- 1
- Citations
- 0
External Links
Identifiers
- ROR
- https://ror.org/03jckbw05